title: Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas.
abstract: OBJECTIVE
  The Gynecologic Cancer InterGroup aimed to provide an overview of uterine and ovarian leiomyosarcoma management.
  
  
  METHODS
  Published articles and author experience were used to draft management overview. The draft manuscript was circulated to international members of the Gynecologic Cancer InterGroup for review and comment, and appropriate revisions were made.
  
  
  RESULTS
  The approach to management of uterine and ovarian leiomyosarcoma management is reviewed.
  
  
  CONCLUSIONS
  Uterine and ovarian leiomyosarcomas are rare and aggressive cancers that require specialized expertise for optimal management.
authors.affiliation: *Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY; †Mayo Clinic, Rochester, MN, GOG; ‡Gynäkologische Endokrinologie und Onkologie Universitätsklinikum Gießen und Marburg GmbH, AGO; §Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT, RTOG; ∥Peter MacCallum Cancer Centre, Royal Women's Hospital, University of Melbourne, Melbourne, Australia, ANZOG; ¶Seoul National University College of Medicine, KGOG; #University of Tampere, Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland, NSGO; **Institut Gustave-Roussy, Villejuif, France, GINECO; ††NHS Greater Glasgow and Clyde, Glasgow Royal Infirmary, Glasgow, Scotland, SGCTG; ‡‡Academic Medical Center, Amsterdam, Netherlands, DGOG; §§Centre Léon Bérard, Lyon, GINECO.
authors.forename: Martee L
authors.initials: ML
authors.lastname: Hensley
authors.forename: Brigitte A
authors.initials: BA
authors.lastname: Barrette
authors.forename: Klaus
authors.initials: K
authors.lastname: Baumann
authors.forename: David
authors.initials: D
authors.lastname: Gaffney
authors.forename: Anne L
authors.initials: AL
authors.lastname: Hamilton
authors.forename: Jae-Weon
authors.initials: JW
authors.lastname: Kim
authors.forename: Johanna U
authors.initials: JU
authors.lastname: Maenpaa
authors.forename: Patricia
authors.initials: P
authors.lastname: Pautier
authors.forename: Nadeem Ahmad
authors.initials: NA
authors.lastname: Siddiqui
authors.forename: Anneke M
authors.initials: AM
authors.lastname: Westermann
authors.forename: Isabelle
authors.initials: I
authors.lastname: Ray-Coquard
mesh_terms: D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007890:Leiomyosarcoma / Q000473:pathology* / Q000628:therapy; D008495:Medical Oncology; D010051:Ovarian Neoplasms / Q000473:pathology* / Q000628:therapy; D017410:Practice Guidelines as Topic; D012955:Societies, Medical; D014594:Uterine Neoplasms / Q000473:pathology* / Q000628:therapy